ZA957549B - Fluoroalkyl/alkenyl-substituted benzoylguanidines process for their preparation their use as a medicament or diagnostic and medicament containing them - Google Patents

Fluoroalkyl/alkenyl-substituted benzoylguanidines process for their preparation their use as a medicament or diagnostic and medicament containing them

Info

Publication number
ZA957549B
ZA957549B ZA957549A ZA957549A ZA957549B ZA 957549 B ZA957549 B ZA 957549B ZA 957549 A ZA957549 A ZA 957549A ZA 957549 A ZA957549 A ZA 957549A ZA 957549 B ZA957549 B ZA 957549B
Authority
ZA
South Africa
Prior art keywords
alkyl
medicament
cycloalkyl
alkenyl
fluoroalkyl
Prior art date
Application number
ZA957549A
Other languages
English (en)
Inventor
Andreas Weichert
Heinz-Werner Kleeman
Hans-Jochen Lang
Jan-Robert Schwark
Udo Albus
Wolfgang Scholz
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA957549B publication Critical patent/ZA957549B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Surgery (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ZA957549A 1994-09-09 1995-09-08 Fluoroalkyl/alkenyl-substituted benzoylguanidines process for their preparation their use as a medicament or diagnostic and medicament containing them ZA957549B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4432105A DE4432105A1 (de) 1994-09-09 1994-09-09 Fluoro-alkyl/alkenyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (1)

Publication Number Publication Date
ZA957549B true ZA957549B (en) 1996-04-17

Family

ID=6527787

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA957549A ZA957549B (en) 1994-09-09 1995-09-08 Fluoroalkyl/alkenyl-substituted benzoylguanidines process for their preparation their use as a medicament or diagnostic and medicament containing them

Country Status (24)

Country Link
US (2) US5869531A (no)
EP (1) EP0702001B1 (no)
JP (1) JPH0899950A (no)
KR (1) KR960010620A (no)
CN (1) CN1063436C (no)
AT (1) ATE195725T1 (no)
AU (1) AU698629B2 (no)
CA (1) CA2157856C (no)
CZ (1) CZ290027B6 (no)
DE (2) DE4432105A1 (no)
DK (1) DK0702001T3 (no)
ES (1) ES2151572T3 (no)
FI (1) FI954191A (no)
GR (1) GR3034512T3 (no)
HU (1) HU221851B1 (no)
IL (1) IL115194A (no)
NO (2) NO305117B1 (no)
NZ (1) NZ272948A (no)
PL (1) PL181206B1 (no)
PT (1) PT702001E (no)
RU (1) RU2159762C2 (no)
SI (1) SI9500281B (no)
TW (1) TW382621B (no)
ZA (1) ZA957549B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19540995A1 (de) * 1995-11-03 1997-05-07 Hoechst Ag Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19542306A1 (de) * 1995-11-14 1997-05-15 Hoechst Ag Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
PL316439A1 (en) * 1995-11-20 1997-05-26 Hoechst Ag Novel substituted derivatives of benzoyloguanidine, method of obtaining them, their application in production of pharmaceutic and diagnostic agents and pharmaceutic agent as such
DE19546736A1 (de) * 1995-12-14 1997-06-19 Hoechst Ag Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate
JP4745432B2 (ja) * 2009-09-30 2011-08-10 住友大阪セメント株式会社 光導波路素子

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780027A (en) * 1970-04-29 1973-12-18 Merck & Co Inc Anthranilic acid derivatives
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
DK0556674T3 (da) * 1992-02-15 1996-10-14 Hoechst Ag 3,5-Substituerede benzoylguanidiner med antiarytmisk virkning og inhiberende virkning på celleproliferation
DE4237035A1 (de) * 1992-11-03 1994-05-05 Vorwerk Co Interholding Staubfilterbeutel für einen Staubsauger
TW250477B (no) * 1992-12-15 1995-07-01 Hoechst Ag
EP0604852A1 (de) * 1992-12-28 1994-07-06 Hoechst Aktiengesellschaft 2,4-Substituierte 5-(N-substituierte-Sulfamoyl)-Benzoylguanidine, als Antiarrythmika, Inhibitoren der Proliferationen von Zellen, und Inhibitoren des Natrium-Protonen-Antiporters
ES2107698T3 (es) * 1993-02-20 1997-12-01 Hoechst Ag Benzoilguanidinas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento, como inhibidores del intercambio celular de na+/h+ o como agente de diagnostico, asi como medicamento que las contiene.

Also Published As

Publication number Publication date
PL310345A1 (en) 1996-03-18
FI954191A0 (fi) 1995-09-07
KR960010620A (ko) 1996-04-20
CA2157856A1 (en) 1996-03-10
ATE195725T1 (de) 2000-09-15
HU221851B1 (hu) 2003-02-28
PT702001E (pt) 2001-01-31
RU2159762C2 (ru) 2000-11-27
CZ231695A3 (en) 1996-03-13
DK0702001T3 (da) 2000-10-16
SI9500281B (en) 2001-12-31
CA2157856C (en) 2007-11-13
NZ272948A (en) 1996-07-26
EP0702001B1 (de) 2000-08-23
US5998481A (en) 1999-12-07
IL115194A (en) 2003-01-12
NO985244D0 (no) 1998-11-10
NO985244L (no) 1996-03-11
NO953554D0 (no) 1995-09-08
SI9500281A (en) 1996-04-30
AU3050595A (en) 1996-03-21
NO953554L (no) 1996-03-11
CN1063436C (zh) 2001-03-21
GR3034512T3 (en) 2000-12-29
HUT72652A (en) 1996-05-28
AU698629B2 (en) 1998-11-05
NO306293B1 (no) 1999-10-18
ES2151572T3 (es) 2001-01-01
PL181206B1 (pl) 2001-06-29
CN1128752A (zh) 1996-08-14
US5869531A (en) 1999-02-09
NO305117B1 (no) 1999-04-06
EP0702001A1 (de) 1996-03-20
IL115194A0 (en) 1995-12-31
DE4432105A1 (de) 1996-03-14
HU9502633D0 (en) 1995-11-28
CZ290027B6 (cs) 2002-05-15
TW382621B (en) 2000-02-21
JPH0899950A (ja) 1996-04-16
FI954191A (fi) 1996-03-10
DE59508654D1 (de) 2000-09-28

Similar Documents

Publication Publication Date Title
GR3030231T3 (en) Phenylsubstituted alkenyl-carboxylic-acid-guanidines containing perfluoroalkyl groups, process for their preparation, their use as medicament or diagnostic agent, as well as a medicament containing them
FI952290A (fi) Perfluorialkyylillä substituoidut bentsoyyliguanidiinit, menetelmä niiden valmistamiseksi, niiden käyttö lääkeaineena tai diagnostisena aineena sekä niitä sisältävä lääkeaine
ATE191480T1 (de) Oxazolidin-2-onderivate als mao-inhibitoren
ZA957549B (en) Fluoroalkyl/alkenyl-substituted benzoylguanidines process for their preparation their use as a medicament or diagnostic and medicament containing them
DK0516297T3 (da) Pyridazindioner og deres anvendelse ved behandling af neurologiske sygdomme
Hafner et al. Synthesis and structure of the first [22] metallocenophanes
DE3061648D1 (en) Pyrimido and imidazo-pyrido-indole-diones, their preparation and therapeutic use
DE3778666D1 (de) 6,7-dihydro-(1,2,4)triazolo(1,5-a)(1,3,5)triazin-2-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider und wachstumsregulierender wirkung.
ES8604591A1 (es) Procedimiento para preparar nuevas 11-piperazinil-5h-imidazo(2,1-c)(1,4)-benzodiazepinas